ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

Cancer Groups In Campaign To Draft Pazdur For FDA.

March 2, 2001

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

Letter to the Editors: Scientists, Media Shouldn’t Overstate “Breakthroughs”

May 29, 1998

In Brief: Gaus Heads AHCPR; Lineberger Names New Leadership In Oncology and Clinical Research

July 22, 1994

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

Breast Cancer Task Force Hears Update on Research, Abstract Excerpter

September 19, 1980